Postoperative pain management remains a significant challenge, yet many clinicians underestimate its complexity—and the innovative solutions like Transcutaneous Electrical Acupoint Stimulation (TEAS) are changing the landscape. But here's where it gets controversial... Does TEAS truly offer a superior, non-invasive alternative to traditional analgesics, or is it just another complementary therapy with limited real-world impact?
Introduction
Laparoscopic hysterectomy (LH) is renowned for its minimally invasive approach, characterized by small incisions, low surgical risk, and faster recovery periods. Yet, despite these advantages, patients often underestimate the intensity of postoperative pain. Postoperative discomfort following LH isn't limited to the surgical incision; it manifests in various forms, including visceral pain (deep within the abdomen), low back pain (LBP), and shoulder pain. These pain types primarily stem from factors such as the stretch caused by pneumoperitoneum (the insufflation of gas into the abdominal cavity), direct tissue trauma during surgery, neuroinflammatory responses, and irritation of the peritoneum. Multiple studies reveal that over 70% of patients experience moderate to severe pain after LH, with visceral pain and low back discomfort being the most prevalent.
Uncontrolled pain can activate the sympathetic nervous system excessively and impair effective breathing, potentially leading to more severe complications like myocardial ischemia, arrhythmias, and lung collapse (atelectasis). Opioids, the mainstay pain relief agents, work by binding to specific receptors in the nervous system to block pain signals. However, high doses often fall short of providing complete relief and risk severe side effects such as nausea, vomiting, bowel paralysis (ileus), and itching. These issues highlight the necessity for alternative or adjunct pain management strategies.
Understanding TEAS and Its Mechanisms
Transcutaneous electrical acupoint stimulation (TEAS) emerges as a promising non-invasive technique that combines traditional acupoint therapy with modern electrical nerve stimulation (TENS). Compared to TENS, TEAS is safer, more comfortable, and generally better tolerated by patients, leading to higher compliance rates. Evidence suggests TEAS exerts its analgesic effects via multiple interconnected pathways:
- Activation of the brain’s endogenous opioid system by stimulating certain frequencies (like 2/100 Hz), prompting the body to release natural painkillers such as enkephalins and endorphins.
- Induction of serotonin and norepinephrine release within the spinal cord, reducing the excitability of pain neurons in the dorsal horn.
- Modulation of inflammatory mediators like tumor necrosis factor-alpha (TNF-α) and interleukins (e.g., IL-6, IL-4), which can sensitize pain pathways when elevated.
These combined effects create a holistic, multi-level approach to pain relief, addressing not only the neural pathways but also the body's inflammatory response.
Recent Evidence Through Randomized Controlled Trials
Recent high-quality clinical trials have demonstrated TEAS’s promising role in post-surgical pain management, showing reductions in pain scores, decreased reliance on opioids, and faster recovery times. What's most exciting—and perhaps most overlooked—is that despite extensive research on general postoperative pain, little attention has been paid to how TEAS influences specific pain phenotypes like visceral, incisional, or low back pain. Furthermore, most studies only follow up for a short duration, leaving questions about long-term benefits or the potential to prevent chronic pain unresolved.
In our recent study, we hypothesized that TEAS might be particularly effective against visceral pain following LH, given its mechanisms. To explore this, we designed a rigorous randomized controlled trial (RCT)—with participants receiving either real TEAS or sham stimulation—carefully measuring pain levels at different time points and assessing overall recovery.
Materials, Methods, and Design
This study was ethically approved by the relevant committee and registered in the Chinese Clinical Trial Registry. We enrolled 108 women aged 18-65, all scheduled for elective LH, with specific inclusion criteria ensuring they could understand and complete questionnaires and had no contraindications like skin infections, allergies, or severe health conditions.
Participants were randomly assigned to either the TEAS or sham group, with blinding maintained for patients, clinicians, and outcome assessors. The TEAS protocol involved bilateral stimulation at specific acupoints (LI4, PC6, SP6, ST36), starting 30 minutes before anesthesia and continuing throughout surgery. The control group received sham stimulation with identical electrode placement but without effective electrical input.
We measured various outcomes: pain scores for visceral, low back, and incisional pain (using a numeric scale) over the first two postoperative days, along with inflammatory cytokines, analgesic consumption, adverse events, and recovery parameters such as time to ambulation and hospital discharge.
Analgesic and Surgery Management
All patients underwent standardized anesthesia and surgical procedures. They also received postoperative patient-controlled analgesia with sufentanil, alongside additional rescue medications as needed. The surgical team followed uniform protocols to minimize variability.
Results: What We Found
Out of 120 initially assessed patients, 93 completed the study follow-up. Baseline characteristics were statistically similar between groups, ensuring fair comparisons.
Notably, patients who received TEAS experienced significantly less visceral pain on the day of surgery and the following day, with a lower incidence of moderate-to-severe visceral pain across the first three days. The reduction was also evident in low back pain, persisting for up to two days post-surgery. However, TEAS did not produce notable improvements in incisional pain, likely because all patients received local anesthetic infiltration around the wound, which may have masked additional benefits.
In terms of biological markers, plasma IL-6 levels—indicators of inflammation—were lower in the TEAS group on postoperative day 1, hinting at TEAS’s anti-inflammatory effects. Similarly, TEAS reduced the need for opioids, as evidenced by lower sufentanil consumption and fewer demands on patient-controlled analgesia. Patients in this group also experienced quicker removal of pelvic drains, earlier mobilization, and shorter hospital stays, along with a reduced incidence of postoperative nausea and vomiting.
While the low incidence of shoulder pain (PLSP) prevented us from thoroughly analyzing TEAS’s effect on this particular complication, the preliminary data suggest potential benefits worth further exploration.
Discussion and Broader Implications
This study underscores the potential of TEAS as an effective, non-invasive adjunct for managing specific types of postoperative pain. Its ability to significantly reduce visceral and low back pain, along with dampening the inflammatory response, contributes to faster recovery and fewer adverse effects. Why does TEAS seem to work better for visceral and back pain? Likely because these pain sensations involve different neural pathways compared to incisional pain, which in our case was effectively managed by local anesthetics.
Additionally, the stimulation of points such as PC6 and LI4 not only centralizes analgesia but also provides anti-emetic and anxiolytic benefits—crucial for a smooth postoperative course. The effects on inflammatory cytokines, particularly IL-6, further support TEAS’s role in modulating body responses beyond mere neural effects.
Despite promising findings, the study has limitations: it's conducted at a single center with a modest sample size, possibly limiting generalizability. Future larger, multi-center trials could provide more definitive evidence and explore long-term outcomes, including the prevention of chronic postoperative pain.
And this is the part most people miss: While TEAS shows promise, it should be viewed as part of a multimodal analgesic strategy—not a standalone fix. Combining TEAS with pharmacological and physical therapies may offer the best patient outcomes.
Conclusion
In summary, TEAS demonstrates significant benefits in reducing visceral and low back pain after LH, along with decreased inflammation, reduced opioid use, and faster recovery. These results support integrating TEAS into multimodal pain management protocols and Enhanced Recovery After Surgery (ERAS) pathways. As always, ongoing dialogue and clinical trials will determine how widely this promising modality will revolutionize postoperative care.
What do you think—could TEAS be a game-changer in your practice? Or is it just another adjunct with limited effects? Share your perspectives below!
